Biolase Company Profile (NASDAQ:BIOL)

About Biolase

Biolase logoBIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIOL
  • CUSIP:
Key Metrics:
  • Previous Close: $1.51
  • 50 Day Moving Average: $1.55
  • 200 Day Moving Average: $1.58
  • 52-Week Range: $67,565,000.00 - $0.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -19.13
  • P/E Growth: -0.54
  • Market Cap: $103.38B
  • Outstanding Shares: 67,565,000
  • Beta: 1.89
Profitability:
  • Net Margins: -25.50%
  • Return on Equity: -53.73%
  • Return on Assets: -30.49%
Debt:
  • Current Ratio: 2.27%
  • Quick Ratio: 1.44%
Additional Links:
Companies Related to Biolase:

Analyst Ratings

Consensus Ratings for Biolase (NASDAQ:BIOL) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biolase (NASDAQ:BIOL)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Biolase (NASDAQ:BIOL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2017        
11/8/2016Q316($0.02)($0.07)$12.40 million$13.20 millionViewListenView Earnings Details
5/9/2016Q116($0.03)($0.07)$11.90 million$11.00 millionViewN/AView Earnings Details
3/9/2016Q415($0.09)($0.02)$13.90 million$14.50 millionViewN/AView Earnings Details
11/4/2015Q315($0.08)($0.09)$1.50 million$11.20 millionViewN/AView Earnings Details
8/5/2015Q215($0.06)($0.10)$12.30 million$11.90 millionViewN/AView Earnings Details
3/4/2015Q414($0.04)($0.06)$14.90 million$13.20 millionViewN/AView Earnings Details
11/4/2014Q314($0.09)($0.08)$11.70 million$12.70 millionViewN/AView Earnings Details
8/7/2014Q214($0.08)($0.17)$12.97 million$10.20 millionViewN/AView Earnings Details
5/12/2014Q114($0.05)($0.11)$13.29 million$11.50 millionViewN/AView Earnings Details
3/5/2014Q413($0.04)($0.04)$15.67 million$15.20 millionViewN/AView Earnings Details
11/5/2013Q313($0.05)($0.10)$16.42 million$12.30 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.04)($0.06)$15.69 million$14.20 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.01)($0.06)$14.48 million$14.60 millionViewN/AView Earnings Details
3/6/2013Q4 2012$0.05$18.03 million$19.10 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biolase (NASDAQ:BIOL)
Current Year EPS Consensus Estimate: $-0.14 EPS
Next Year EPS Consensus Estimate: $-0.08 EPS

Dividends

Dividend History for Biolase (NASDAQ:BIOL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biolase (NASDAQ:BIOL)
Insider Ownership Percentage: 7.30%
Institutional Ownership Percentage: 34.15%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/18/2016Jack W SchulerMajor ShareholderBuy500$0.80$400.00View SEC Filing  
2/17/2016Jack W SchulerMajor ShareholderBuy4,100$0.80$3,280.00View SEC Filing  
2/12/2016Jack W SchulerMajor ShareholderBuy19,080$0.76$14,500.80View SEC Filing  
2/10/2016Jack W SchulerMajor ShareholderBuy67,213$0.78$52,426.14View SEC Filing  
1/25/2016Jack W SchulerMajor ShareholderBuy1,400$0.80$1,120.00View SEC Filing  
1/22/2016Jack W SchulerMajor ShareholderBuy6,670$0.78$5,202.60View SEC Filing  
1/20/2016Jack W SchulerMajor ShareholderBuy24,200$0.75$18,150.00View SEC Filing  
12/28/2015Jack W SchulerMajor ShareholderBuy18,350$0.79$14,496.50View SEC Filing  
12/24/2015Jack W SchulerMajor ShareholderBuy41,900$0.76$31,844.00View SEC Filing  
12/22/2015Jack W SchulerMajor ShareholderBuy87,200$0.74$64,528.00View SEC Filing  
12/21/2015Jack W SchulerMajor ShareholderBuy127,892$0.73$93,361.16View SEC Filing  
12/17/2015Jack W SchulerMajor ShareholderBuy34,158$0.70$23,910.60View SEC Filing  
11/11/2015Larry N FeinbergMajor ShareholderBuy54,800$0.79$43,292.00View SEC Filing  
11/10/2015Paul N ClarkDirectorBuy134,579$0.75$100,934.25View SEC Filing  
9/24/2015David C DreyerCFOBuy5,000$1.20$6,000.00View SEC Filing  
9/22/2015David C DreyerCFOBuy5,000$1.37$6,850.00View SEC Filing  
9/17/2015David C DreyerCFOBuy10,000$1.45$14,500.00View SEC Filing  
11/3/2014Jeffrey M NugentCEOBuy40,465$2.39$96,711.35View SEC Filing  
11/3/2014Jonathan T Md LordDirectorBuy101,163$2.39$241,779.57View SEC Filing  
11/3/2014Larry N FeinbergMajor ShareholderBuy2,067,979$2.39$4,942,469.81View SEC Filing  
7/22/2014Alexander K ArrowCOOBuy7,812$1.92$14,999.04View SEC Filing  
7/22/2014Frederick D FurryCFOBuy13,020$1.92$24,998.40View SEC Filing  
7/22/2014Jeffrey M NugentCEOBuy52,083$1.92$99,999.36View SEC Filing  
7/22/2014Paul N ClarkDirectorBuy520,833$1.92$999,999.36View SEC Filing  
7/18/2014Larry N FeinbergMajor ShareholderBuy2,270,836$1.92$4,360,005.12View SEC Filing  
2/12/2014Larry N FeinbergMajor ShareholderBuy2,035,033$2.57$5,230,034.81View SEC Filing  
1/31/2014Larry Feinbergmajor shareholderBuy30,798$2.45$75,455.10View SEC Filing  
12/19/2013Larry Feinbergmajor shareholderBuy340,000$1.80$612,000.00View SEC Filing  
12/17/2013Larry Feinbergmajor shareholderBuy150,400$1.87$281,248.00View SEC Filing  
8/23/2012Frederick D FurryCFOBuy5,075$1.64$8,323.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Biolase (NASDAQ:BIOL)
DateHeadline
sbwire.com logoWorldwide Directed Energy-Based Surgical Systems Market Share by Industry Research 2016 - 2024 (NASDAQ:BIOL)
www.sbwire.com - February 17 at 10:49 AM
newsmaker.com.au logoDental Surgical Equipment Market is Expected to Gain Popularity Across the Globe by 2020 (NASDAQ:BIOL)
www.newsmaker.com.au - February 15 at 2:31 AM
News IconWorldwide Directed Energy-based Surgical Systems Market By Analysis of Major Industry Segments 2024 (NASDAQ:BIOL)
reports.pr-inside.com - February 15 at 2:31 AM
News IconDental Diagnostic and Surgical Equipment Market to Grow at a 5.53% CAGR Forecast to 2020 (NASDAQ:BIOL)
empowerednews.net - February 13 at 4:24 PM
News IconBIOLASE Announces the FDA Clearance and Worldwide Launch of New... (NASDAQ:BIOL)
www.topix.com - February 11 at 3:56 PM
News IconDental Curing Light Equipment Industry Sales, Supply and Consumption 2017 Analysis and Forecasts to 2022 (NASDAQ:BIOL)
empowerednews.net - February 11 at 1:27 AM
News IconBIOLASE Inc. Wins FDA Clearance of New Waterlase Express All-Tissue Laser System (NASDAQ:BIOL)
www.biospace.com - February 10 at 3:24 PM
News IconBIOLASE Announces the FDA Clearance and Worldwide Launch of New Waterlase Express All-Tissue Laser System (NASDAQ:BIOL)
www.consumerelectronicsnet.com - February 10 at 3:24 PM
finance.yahoo.com logoBIOLASE Announces the FDA Clearance and Worldwide Launch of New Waterlase Express™ All-Tissue Laser System (NASDAQ:BIOL)
finance.yahoo.com - February 10 at 3:24 PM
finance.yahoo.com logo6:01 am Biolase receives 510(k) clearance for its fifth-generation Waterlas Express for commercial distribution from the FDA in the U.S. as well as select international markets in Europe, the Middle East and Asia (NASDAQ:BIOL)
finance.yahoo.com - February 10 at 3:24 PM
News IconMedical Laser Technology Market Will Generate New Growth Opportunities by 2021 (NASDAQ:BIOL)
www.medgadget.com - February 10 at 2:04 AM
sbwire.com logoGlobal Market for Medical Lasers Is Expected to Reach $12.98 Billion by 2022; Finds New Report (NASDAQ:BIOL)
www.sbwire.com - February 9 at 9:04 PM
News IconBurst Astrophysics (NASDAQ:BIOL)
www.scirp.org - February 8 at 9:09 PM
einnews.com logoDental Surgical and Diagnostic Devices Market is expected to Generate Huge Profits by 2027: Vendors- DENTSPLY, A Dec (NASDAQ:BIOL)
brazilbusiness.einnews.com - February 8 at 2:55 AM
sbwire.com logoWorldwide Dental Equipment Market Key Trends & Industry Forecast 2016 - 2024 (NASDAQ:BIOL)
www.sbwire.com - February 7 at 1:57 AM
News IconCAO GROUP INC v. BIOLASE TECHNOLOGY INC (NASDAQ:BIOL)
caselaw.findlaw.com - February 4 at 3:59 PM
News IconInvestor Sphere: Keeping an Eye on Levels for BIOLASE Inc. (BIOL) - Sherwood Daily (NASDAQ:BIOL)
sherwooddaily.com - February 2 at 9:05 PM
News IconChecking Indicator Levels for BIOLASE Inc. (BIOL) - Sherwood Daily (NASDAQ:BIOL)
sherwooddaily.com - February 1 at 4:08 PM
News IconOn the Hunt For the Next Wonder Stock: Penny Stock BIOLASE, Inc. (NASDAQ:BIOL) - Nelson Research (NASDAQ:BIOL)
nelsonobserver.com - February 1 at 4:08 PM
openpr.com logoGlobal Radiation Energy Based Ablation Devices Market 2017 : BIOLASE Inc, AngioDynamics Inc, Havells USA, ProstaLund AB, Solta Medical Inc. (NASDAQ:BIOL)
www.openpr.com - January 31 at 1:49 AM
News IconEquity Focus: Indicator Check on Shares of BIOLASE Inc. (BIOL) - Sherwood Daily (NASDAQ:BIOL)
sherwooddaily.com - January 30 at 8:47 PM
News IconCan This Stock Make a Ripple in the Market: BIOLASE, Inc. (NASDAQ:BIOL) - Prospect Journal (NASDAQ:BIOL)
prospectjournal.com - January 30 at 8:47 PM
News IconBIOLASE, Inc. (NASDAQ:BIOL) Announce FDA Clearance and Worldwide Launch of Its New Epic Pro™ Diode Laser ... - Nelson Observer (NASDAQ:BIOL)
nelsonobserver.com - January 30 at 3:46 PM
News IconMedtronic Visualase System Used in Mayo Clinic Epilepsy Trial (NASDAQ:BIOL)
www.photonics.com - January 28 at 2:09 AM
News IconLooking at the Gauges on BIOLASE Inc. (BIOL) - Sherwood Daily (NASDAQ:BIOL)
sherwooddaily.com - January 27 at 8:59 PM
News IconLiquid Lens Paired with Infrared Light and a Smartphone Creates Smart Glasses (NASDAQ:BIOL)
www.photonics.com - January 27 at 2:35 AM
News IconIs This Equity Ready for a Breakout: BIOLASE, Inc. (NASDAQ:BIOL) - Prospect Journal (NASDAQ:BIOL)
prospectjournal.com - January 26 at 9:35 PM
News IconBiolase Epic Pro Dental Laser Receives FDA Approval - Photonics.com (NASDAQ:BIOL)
www.photonics.com - January 26 at 4:34 PM
News IconMarket Rover: Looking at Levels on Shares of BIOLASE Inc. (BIOL) - Sherwood Daily (NASDAQ:BIOL)
sherwooddaily.com - January 26 at 4:34 PM
News IconStock Review: Checking in on Share of BIOLASE, Inc. (NASDAQ:BIOL) - The Tribune (NASDAQ:BIOL)
lakecitytribune.com - January 26 at 4:34 PM
istreetwire.com logoInvestor's Watch List: Square, Inc. (SQ), BIOLASE, Inc. (BIOL), Array BioPharma Inc. (ARRY) - iStreetWire (NASDAQ:BIOL)
istreetwire.com - January 25 at 4:24 PM
News IconTrading Views: Checking the Numbers for BIOLASE Inc. (BIOL) - Sherwood Daily (NASDAQ:BIOL)
sherwooddaily.com - January 25 at 4:24 PM
News IconIs Trouble Brewing For This Stock? Shares Gapping Lower: BIOLASE, Inc. (NASDAQ:BIOL) - Aiken Advocate (NASDAQ:BIOL)
aikenadvocate.com - January 25 at 4:24 PM
News IconAnalyst's Review on: BIOLASE Inc (NASDAQ:BIOL) - Post Registrar (NASDAQ:BIOL)
postregistrar.com - January 25 at 4:24 PM
businesswire.com logoBIOLASE Announces the FDA Clearance and Worldwide Launch of Its New Epic Pro™ Diode Laser System - Business Wire (press release) (NASDAQ:BIOL)
www.businesswire.com - January 25 at 4:24 PM
News IconResearch Report Covers the Dental Diagnostic & Surgical Equipment Market Share and Growth, 2015-2025 (NASDAQ:BIOL)
www.ssuchronicle.com - January 24 at 4:27 PM
News IconBIOLASE announces FDA clearance of Epic Pro diode laser system (NASDAQ:BIOL)
www.dotmed.com - January 24 at 4:27 PM
News IconDiscover the Global dental lasers market research for 2017 (NASDAQ:BIOL)
www.whatech.com - January 23 at 8:20 PM
us.rd.yahoo.com logo6:01 am Biolase confirms 510(k) clearance for commercial distribution in the US of its Epic Pro laser system from the FDA (NASDAQ:BIOL)
us.rd.yahoo.com - January 23 at 8:20 PM
News IconInvesting Focus: Indicators in View on Shares of BIOLASE Inc. (BIOL) - Sherwood Daily (NASDAQ:BIOL)
sherwooddaily.com - January 23 at 3:19 PM
News IconPeculiar Activity & Volume Noted in Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Aiken Advocate (NASDAQ:BIOL)
aikenadvocate.com - January 23 at 3:19 PM
News IconPriming The Pump: Stock Volatility Spotted in BIOLASE, Inc. (NASDAQ:BIOL) - Wall Street Beacon (NASDAQ:BIOL)
wsbeacon.com - January 23 at 3:18 PM
News IconStock To Watch: BIOLASE Inc (NASDAQ:BIOL) Gets FDA Approval ... - Stock Market Daily (blog) (NASDAQ:BIOL)
stockmarketdaily.co - January 23 at 3:18 PM
News IconGlobal Radiation Energy Based Ablation Devices Market 2016 : BIOLASE Inc. (US), Dornier MedTech GmbH (Germany) - Medgadget (blog) (NASDAQ:BIOL)
www.medgadget.com - January 21 at 9:15 PM
News IconGlobal Dental Lasers Market Forecast to 2024 – A New Report by Data Bridge Market Research (NASDAQ:BIOL)
empowerednews.net - January 21 at 3:52 PM
News IconStock Overview: Moving Average Check on BIOLASE Inc. (BIOL) - Sherwood Daily (NASDAQ:BIOL)
sherwooddaily.com - January 19 at 3:24 PM
News IconAre There Any Catalysts to Propel This Stock Forward: BIOLASE, Inc. (NASDAQ:BIOL) - Prospect Journal (NASDAQ:BIOL)
prospectjournal.com - January 19 at 3:24 PM
News IconTrend Strength Monitor on Shares of BIOLASE Inc. (BIOL) - Sherwood Daily (NASDAQ:BIOL)
sherwooddaily.com - January 18 at 3:20 PM
News IconShooting From the Hip, Stock Reaches Most Volatile List: BIOLASE, Inc. (NASDAQ:BIOL) - Wall Street Beacon (NASDAQ:BIOL)
wsbeacon.com - January 18 at 3:19 PM
News IconHoning in on Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Prospect Journal (NASDAQ:BIOL)
prospectjournal.com - January 17 at 9:41 PM

Social

What is Biolase's stock symbol?

Biolase trades on the NASDAQ under the ticker symbol "BIOL."

When will Biolase announce their earnings?

Biolase is scheduled to release their next quarterly earnings announcement on Tuesday, March, 7th 2017.

Who owns Biolase stock?

Biolase's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Birchview Capital LP (1.90%), Teton Advisors Inc. (0.51%) and Gamco Investors INC. ET AL (0.13%). Company insiders that own Biolase stock include David C Dreyer, Jack W Schuler, Larry N Feinberg and Paul N Clark.

Who sold Biolase stock? Who is selling Biolase stock?

Biolase's stock was sold by a variety of institutional investors in the last quarter, including Gamco Investors INC. ET AL.

How do I buy Biolase stock?

Shares of Biolase can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Biolase stock cost?

One share of Biolase stock can currently be purchased for approximately $1.53.

Biolase (NASDAQ:BIOL) Chart for Sunday, February, 19, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Biolase (NASDAQ:BIOL)

Earnings History Chart

Earnings by Quarter for Biolase (NASDAQ:BIOL)

Dividend History Chart

Dividend Payments by Quarter for Biolase (NASDAQ:BIOL)

Last Updated on 2/19/2017 by MarketBeat.com Staff